Safety and Immunogenicity of 20vPnC Coadministered With SIIV in Adults ≥65 Years of Age. Final Report: A Phase 3, Randomized, Double-Blind Trial to Evaluate the Safety and Immunogenicity of a 20-valent Pneumococcal Conjugate Vaccine (20vPnC) When Coadministered With Seasonal Inactivated Influenza Vaccine (SIIV) in Adults ≥65 Years of Age.